Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 12 studies | 26% ± 10% | |
lung | 10 studies | 29% ± 12% | |
intestine | 6 studies | 24% ± 9% | |
brain | 6 studies | 31% ± 7% | |
kidney | 5 studies | 20% ± 5% | |
liver | 4 studies | 29% ± 14% | |
placenta | 3 studies | 20% ± 4% | |
bone marrow | 3 studies | 26% ± 11% | |
uterus | 3 studies | 34% ± 14% | |
breast | 3 studies | 22% ± 8% | |
lymph node | 3 studies | 20% ± 5% | |
adipose | 3 studies | 17% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 8591.14 | 459 / 459 | 100% | 68.66 | 1118 / 1118 |
esophagus | 100% | 9578.87 | 1445 / 1445 | 100% | 63.55 | 183 / 183 |
lung | 100% | 7585.24 | 578 / 578 | 100% | 53.14 | 1155 / 1155 |
ovary | 100% | 7950.68 | 180 / 180 | 100% | 41.15 | 430 / 430 |
uterus | 100% | 8941.26 | 170 / 170 | 100% | 57.98 | 459 / 459 |
bladder | 100% | 9556.62 | 21 / 21 | 100% | 52.95 | 503 / 504 |
prostate | 100% | 7637.93 | 245 / 245 | 100% | 43.13 | 501 / 502 |
stomach | 100% | 6262.28 | 359 / 359 | 100% | 55.59 | 285 / 286 |
thymus | 100% | 11420.79 | 653 / 653 | 100% | 53.66 | 602 / 605 |
brain | 100% | 4149.44 | 2632 / 2642 | 100% | 44.99 | 704 / 705 |
intestine | 100% | 8411.56 | 966 / 966 | 99% | 57.93 | 524 / 527 |
pancreas | 100% | 4774.54 | 327 / 328 | 99% | 37.04 | 177 / 178 |
skin | 100% | 11546.11 | 1809 / 1809 | 98% | 43.21 | 463 / 472 |
kidney | 100% | 5563.10 | 89 / 89 | 98% | 37.48 | 879 / 901 |
liver | 100% | 4467.73 | 226 / 226 | 95% | 21.77 | 384 / 406 |
adrenal gland | 100% | 6997.47 | 258 / 258 | 94% | 23.15 | 216 / 230 |
adipose | 100% | 9022.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9599.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 46.44 | 29 / 29 |
muscle | 100% | 7114.21 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 6833.03 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 58.56 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.34 | 1 / 1 |
heart | 97% | 4786.14 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 24.61 | 73 / 80 |
peripheral blood | 66% | 5283.22 | 612 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_0006396 | Biological process | RNA processing |
GO_0001649 | Biological process | osteoblast differentiation |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_0008380 | Biological process | RNA splicing |
GO_0070934 | Biological process | CRD-mediated mRNA stabilization |
GO_1900152 | Biological process | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0017148 | Biological process | negative regulation of translation |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0097452 | Cellular component | GAIT complex |
GO_0016020 | Cellular component | membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0106002 | Cellular component | mCRD-mediated mRNA stability complex |
GO_0071204 | Cellular component | histone pre-mRNA 3'end processing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005829 | Cellular component | cytosol |
GO_0070937 | Cellular component | CRD-mediated mRNA stability complex |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0048027 | Molecular function | mRNA 5'-UTR binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SYNCRIP |
Protein name | Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein) Synaptotagmin binding cytoplasmic RNA interacting protein (Synaptotagmin binding, cytoplasmic RNA interacting protein, isoform CRA_c) Synaptotagmin binding cytoplasmic RNA interacting protein Heterogeneous nuclear ribonucleoprotein Q Synaptotagmin binding cytoplasmic RNA interacting protein (Synaptotagmin binding, cytoplasmic RNA interacting protein, isoform CRA_b) (cDNA FLJ50849, highly similar to Heterogeneous nuclear ribonucleoprotein Q) SYNCRIP protein |
Synonyms | NSAP1 hCG_401112 HNRPQ |
Description | FUNCTION: Heterogenous nuclear ribonucleoprotein (hnRNP) implicated in mRNA processing mechanisms. Component of the CRD-mediated complex that promotes MYC mRNA stability. Isoform 1, isoform 2 and isoform 3 are associated in vitro with pre-mRNA, splicing intermediates and mature mRNA protein complexes. Isoform 1 binds to apoB mRNA AU-rich sequences. Isoform 1 is part of the APOB mRNA editosome complex and may modulate the postranscriptional C to U RNA-editing of the APOB mRNA through either by binding to A1CF (APOBEC1 complementation factor), to APOBEC1 or to RNA itself. May be involved in translationally coupled mRNA turnover. Implicated with other RNA-binding proteins in the cytoplasmic deadenylation/translational and decay interplay of the FOS mRNA mediated by the major coding-region determinant of instability (mCRD) domain. Interacts in vitro preferentially with poly(A) and poly(U) RNA sequences. Isoform 3 may be involved in cytoplasmic vesicle-based mRNA transport through interaction with synaptotagmins. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation; seems not to be essential for GAIT complex function. . |
Accessions | ENST00000676637.1 [O60506-3] ENST00000678589.1 A0A7I2V309 ENST00000683074.1 F6UXX1 A0A7I2V5Q6 B7Z645 Q05CK9 A0A7I2V2F0 ENST00000683436.1 ENST00000616122.5 A0A7I2V346 ENST00000678930.1 [O60506-2] ENST00000677771.1 ENST00000684462.1 ENST00000678878.1 ENST00000678816.1 A0A7I2YQN2 ENST00000444272 ENST00000678355.1 [O60506-1] ENST00000678528.1 [O60506-3] ENST00000676542.1 A0A7I2YQV8 ENST00000678899.1 ENST00000369622.8 [O60506-1] A0AA34QW03 ENST00000682504.1 ENST00000355238.11 [O60506-3] ENST00000677514.1 O60506 ENST00000677481.1 ENST00000444272.2 [O60506-3] ENST00000678618.1 ENST00000710383.1 A0A7I2V2F2 A0A7I2V4Z0 ENST00000676688.1 [O60506-1] A0A7I2V4J0 ENST00000677059.1 ENST00000676630.1 |